DaVita Clinical Research (DCR) has entered an agreement with Pacific Pharma Group, LLC to provide consulting, program strategy and protocol design support for DCR’s clinical pharmacology studies.   Jon Ruckle, M.D., CPI, principal at Pacific Pharma Group, will collaborate with DCR to continue to expand DCR’s Phase I research capabilities. Dr. Ruckle has served as investigator for more than 350 studies across multiple therapeutic areas including diabetes, cardiovascular disease, hypertension and ...